Fassett RG - Search Results

1

Biomarkers in chronic kidney disease: a review.

Fassett RG, Venuthurupalli SK, Gobe GC, Coombes JS, Cooper MA, Hoy WE. Fassett RG, et al. Kidney Int. 2011 Oct;80(8):806-21. doi: 10.1038/ki.2011.198. Epub 2011 Jun 22. Kidney Int. 2011. PMID: 21697815 Free article. Review.

2

Homocysteine-lowering therapy in renal disease.

Austen SK, Coombes JS, Fassett RG. Austen SK, et al. Among authors: fassett rg. Clin Nephrol. 2003 Dec;60(6):375-85. doi: 10.5414/cnp60375. Clin Nephrol. 2003. PMID: 14690253 Review.

3

Homocysteine and cardiovascular disease in renal disease.

Austen SK, Coombes JS, Fassett RG. Austen SK, et al. Among authors: fassett rg. Nephrology (Carlton). 2003 Dec;8(6):285-95. doi: 10.1111/j.1440-1797.2003.00210.x. Nephrology (Carlton). 2003. PMID: 15012699 Review.

4

The relationship between antioxidant supplements and oxidative stress in renal transplant recipients: a review.

Blackhall ML, Coombes JS, Fassett R. Blackhall ML, et al. ASAIO J. 2004 Sep-Oct;50(5):451-7. doi: 10.1097/01.mat.0000138077.90404.c8. ASAIO J. 2004. PMID: 15497384 Review.

5

No relationship between low-density lipoproteins and endothelial function in hemodialysis patients.

Dalton BS, Fassett RG, Geraghty DP, De Ryke R, Coombes JS. Dalton BS, et al. Among authors: fassett rg. Int J Cardiol. 2005 Mar 18;99(2):307-14. doi: 10.1016/j.ijcard.2004.02.004. Int J Cardiol. 2005. PMID: 15749192

6

Cyclosporine A induced changes to plasma and erythrocyte antioxidant defences.

Fletcher LA, Fassett RG, Richards RS, Coombes JS. Fletcher LA, et al. Among authors: fassett rg. Redox Rep. 2005;10(1):2-8. doi: 10.1179/135100005X21543. Redox Rep. 2005. PMID: 15829105

7

Effects of antioxidant supplementation on blood cyclosporin A and glomerular filtration rate in renal transplant recipients.

Blackhall ML, Fassett RG, Sharman JE, Geraghty DP, Coombes JS. Blackhall ML, et al. Among authors: fassett rg. Nephrol Dial Transplant. 2005 Sep;20(9):1970-5. doi: 10.1093/ndt/gfh875. Epub 2005 Jul 5. Nephrol Dial Transplant. 2005. PMID: 15998657 Clinical Trial.

8

Cyclosporine A-induced changes to erythrocyte redox balance is time course-dependent.

Lexis LA, Richards RS, Fassett RG, Coombes JS. Lexis LA, et al. Among authors: fassett rg. Basic Clin Pharmacol Toxicol. 2005 Sep;97(3):135-40. doi: 10.1111/j.1742-7843.2005.pto_973120.x. Basic Clin Pharmacol Toxicol. 2005. PMID: 16128906 Free article.

9

Acute exposure to cyclosporine does not increase plasma homocysteine in rats.

Austen SK, Fletcher LA, Fassett RG, Booth C, Coombes JS. Austen SK, et al. Among authors: fassett rg. Transplant Proc. 2005 Dec;37(10):4543-6. doi: 10.1016/j.transproceed.2005.11.012. Transplant Proc. 2005. PMID: 16387165

10

Antioxidant supplementation enhances erythrocyte antioxidant status and attenuates cyclosporine-induced vascular dysfunction.

Lexis LA, Fenning A, Brown L, Fassett RG, Coombes JS. Lexis LA, et al. Among authors: fassett rg. Am J Transplant. 2006 Jan;6(1):41-9. doi: 10.1111/j.1600-6143.2005.01154.x. Am J Transplant. 2006. PMID: 16433755 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

165 results

Search Page